Detalles de la búsqueda
1.
A Phase I, Randomized, Double-Blind, Laser-Evoked Potential Study to Evaluate the Analgesic/Antihyperalgesic Effect of ASP9226, a State-Dependent N-Type Voltage-Gated Calcium Channel Inhibitor, in Healthy Male Subjects.
Pain Med
; 19(11): 2246-2255, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29378016
2.
Safety and tolerability of solifenacin add-on therapy to α-blocker treated men with residual urgency and frequency.
J Urol
; 189(1 Suppl): S129-34, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234618
3.
Urodynamics and safety of the ß3-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
J Urol
; 190(4): 1320-7, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23727415
4.
Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status.
Int Urogynecol J
; 21(7): 847-54, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20339833
5.
Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.
J Urol
; 182(6): 2825-30, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19837435
6.
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.
Cancer Chemother Pharmacol
; 77(3): 549-58, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26811179
7.
Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Eur Urol
; 63(1): 158-65, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22831853
8.
Treatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial.
Urology
; 73(1): 14-8, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18995887
Resultados
1 -
8
de 8
1
Próxima >
>>